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Influence of Body Weight on Surgical
Treatment for Neurogenic Thoracic Outlet
Syndrome
J. Westley Ohman, Ahmmad A. Abuirqeba, Senthil N. Jayarajan, Joshua Balderman,
and Robert W. Thompson, St. Louis, Missouri
Background: Body weight affects outcomes of surgical treatment for various conditions, but its
effects on the treatment of neurogenic thoracic outlet syndrome (NTOS) are unknown. The pur-
pose of this study was to evaluate the influence of body weight on technical and functional out-
comes of surgical treatment for NTOS.
Methods: A retrospective review of prospectively collected data was conducted for 265
patients who underwent supraclavicular decompression for NTOS between January 1,
2014 and March 31, 2016. Patients were grouped according to 6 standard body mass index
(BMI) categories. The influence of BMI on measures of surgical outcome was analyzed using
Pearson correlation statistics, analysis of variance (ANOVA), and multivariate logistic
regression.
Results: Mean patient age was 33.3 ± 0.7 years (range, 12e70), and 208 (78%) patients were
women. Mean BMI was 27.2 ± 0.4 (range 16.8e49.9), with 7 underweight (3%), 95 normal
(36%), 84 overweight (32%), 47 obese-I (18%), 15 obese-II (6%), and 17 obese-III (6%). There
was a slight but significant association between BMI and age (Pearson P < 0.0001, r ¼ 0.264;
ANOVA P ¼ 0.0002), but no correlations between BMI and other preoperative variables. There
were no differences between BMI groups for intraoperative, immediate postoperative, or
3-month outcomes. Multivariate logistic regression demonstrated that BMI had no significant
effect on functional outcome as measured by the extent of improvement in Disability of the
Arm, Shoulder, and Hand score at 3 months (P ¼ 0.429).
Conclusions: There was no substantive influence of BMI on preoperative characteristics or
intraoperative, postoperative, or 3-month outcomes for patients with NTOS, and no indication
of an ‘‘obesity paradox’’ for this condition. Supraclavicular decompression for NTOS achieves
similar outcomes across the BMI spectrum.
INTRODUCTION
The worldwide prevalence of obesity has increased
over the past several decades. In the United States,
current data indicate that 69% of adults are over-
weight, with 35% meeting criteria for obesity.1
These findings have broad implications for medical
care given strong associations between obesity and
diabetes, hypertension, hyperlipidemia, and other
conditions. Increased body weight may also affect
the incidence and outcomes of treatment for surgi-
cal diseases, by increasing the technical difficulty
of abdominal and pelvic operations, elevating the
risk of postoperative complications (such as wound
infection and dehiscence, pneumonia, obstructive
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sleep apnea, and deep vein thrombosis), and pro-
longing hospital stay, recovery from operation,
and functional rehabilitation.2e12
The effect of bodyweight on the conduct and out-
comes of surgical treatment has been widely stud-
ied, with increased cardiovascular risk observed at
higher body mass index (BMI) categories and an
increased incidence of cardiovascular complications
regardless of other risk factors.2,13,14 Prospective
cohort studies in general surgery have also shown
surgical site infections, and postoperative mortality
are positively associated with obesity.3,7e10,12 How-
ever, when stratified by body weight category, the
lowest risk for postoperative mortality has been
among those overweight and in obesity class I,
giving rise to the concept of an ‘‘obesity paradox’’
in which mild elevations in BMI seem to be
protective.5,11,12
Neurogenic thoracic outlet syndrome (NTOS) is
an uncommon condition caused by dynamic
brachial plexus nerve compression within the
supraclavicular scalene triangle and/or the subcora-
coid (pectoralis minor) space, resulting in positional
upper extremity pain, numbness, and paresthesia.15
NTOS can be particularly disabling because this con-
dition often affects young, active, individuals in the
prime working years. The outcomes of surgical
treatment for NTOS have been examined with
increasing rigor over the past decade, in part to
help better identify factors that influence treatment
results, but to date, there have been no studies
addressing the potential effects of body weight on
outcomes of surgical treatment for NTOS.16e26 The
purpose of this study was to evaluate the effect of
body weight on intraoperative, technical, postoper-
ative, and functional outcomes following supracla-




All subjects in this study gave informed consent for
the publication of their medical data, through a
protocol approved by the Human Research Protec-
tion Office at Washington University, St. Louis,
Missouri. The study population consisted of all pa-
tients undergoing surgical treatment for NTOS at
the Washington University Center for Thoracic
Outlet Syndrome at Barnes-Jewish Hospital
(St. Louis, MO) from January 1, 2014 to March
31, 2016. Each patient met predefined clinical diag-
nostic criteria for NTOS.24,27e29 Indications for sur-
gical treatment included a sound clinical diagnosis,
significantly disabling symptoms, and absence of
satisfactory improvement following conservative
management with NTOS-specific physical thera-
py.15,20e23 All patients underwent supraclavicular
scalenectomy, first rib resection, and brachial plexus
neurolysis, with concomitant pectoralis minor
tenotomy through an additional deltopectoral
groove incision, when indicated by physical exami-
nation findings, as previously described.15,20e23 Pa-
tients undergoing isolated pectoralis minor
tenotomy as surgical treatment for NTOS were
excluded from analysis. Data were collected from of-
fice notes, hospital records, imaging studies, and re-
cords from treating physicians and therapists,
including Disability of the Arm, Shoulder, and
Hand (DASH) scores to assess functional disability
and entered into a prospectively maintained
database.
Body Weight Groups
Patients were grouped into 6 categories according to
BMI at the time of surgical treatment: (1) under-
weight, BMI < 18.5; (2) normal, BMI 18.6e25.0;
(3) overweight, BMI 25.1e30.0; (4) obese-I, BMI
30.1e35.0; (5) obese-II, BMI 35.1e40.0; or
(6) obese-III, BMI > 40.0.
Statistical Analysis
Descriptive data are presented as the incidence and
proportions for categorical data and as the
mean ± SEM for continuous measures. For analysis
of BMI as a continuous variable, Pearson correlation
tests were performed with calculation of P, r, and R2
values. For analysis of BMI as a categorical variable,
multiple-group comparisons were conducted with
analysis of variance (ANOVA) and Tukey’s multiple
comparisons test, where appropriate.Multivariate lo-
gistic regression was used to analyze associations be-
tween preoperative patient characteristics and
functional outcome. All statistical tests were per-
formed using either Prism, version 6.0 h (GraphPad
Software, Inc., San Diego, CA) or SAS, version 9.3




Two-hundred sixty-five patients underwent surgical
treatment for NTOS between January 1, 2014 and
March 31, 2016. The mean age of the study popula-
tion was 33.3 ± 0.7 years (range, 12 to 70 years).
There were 208 (77%) women, 150 (57%) with
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right-sided symptoms and 28 (10%)with a bony ab-
normality (complete cervical rib, n¼ 9; partial cervi-
cal rib, n ¼ 14; first rib hypoplasia, n ¼ 1; first rib
fracture, n ¼ 3; clavicle fracture, n ¼ 1) (Table I).
Mean BMI was 27.2 ± 0.4 (range 16.8e49.9), with
7 underweight (3%), 95 normal (36%), 84 over-
weight (32%), 47 obese-I (18%), 15 obese-II (6%),
and 17 obese-III (6%) (Table I and Fig. 1A, B). There
was a slight but significant association between BMI
and age (Pearson P < 0.0001, r ¼ 0.264; ANOVA
P ¼ 0.0002), but no correlations were observed be-
tweenBMI and gender, side affected, or the presence
of a bony abnormality. (Table I and Fig. 1C, D).
Clinical Presentation
Approximately half of the patients had a history of a
co-existing medical condition other than NTOS, the
most frequent being anxiety disorder or depression
(n ¼ 59, 22%) and degenerative lumbar spine dis-
ease (n¼ 41, 15%). Cardiac and pulmonary diseases
were infrequent, and diabetes was present in only 6
(2%). There was a history of previous injury in 168
patients (63%), with a relatively even distribution
between recreational, accidental, and occupational
injuries, as well as a smaller number with unclassi-
fied repetitive strain injury (Fig. 2A, B). Over half
of the patients had symptoms for 2 or more years
before referral, consistent with our previous experi-
ence (Fig. 2C, D).20,24,29 Forty-eight patients (18%)
had undergone a previous operation for the present-
ing symptoms without improvement, including pe-
ripheral nerve decompression, cervical spine
operations, or shoulder procedures, with 11 (4%)
having had combined or multiple previous opera-
tions (Fig. 2E, F). While 64% of patients were taking








(25.1e30) Obese-I (30.1e35) Obese-II (35.1e40) Obese-III (>40)
No. of patients (%) 7 (3%) 95 (36%) 84 (32%) 47 (18%) 15 (6%) 17 (6%)
Age (years)* 24 ± 4 30 ± 1 33 ± 1 39 ± 2 38 ± 3 37 ± 2
Female (%)z 7 (100%) 77 (81%) 63 (75%) 36 (77%) 12 (80%) 13 (76%)
Right side (%)z 5 (71%) 60 (63%) 46 (55%) 22 (47%) 8 (53%) 9 (53%)
Rib anomalyz 1 (14%) 16 (17%) 4 (5%) 4 (8%) 2 (13%) 1 (6%)
Height (in)y 65 ± 0.5 67 ± 0.4 67 ± 0.5 66 ± 0.5 66 ± 1.0 66 ± 1.3
Weight (kg)y 48 ± 1 64 ± 1 78 ± 1 89 ± 1 104 ± 3 120 ± 5
BMIy 17 ± 0.2 22 ± 0.2 27 ± 0.2 31 ± 0.2 36 ± 0.3 42 ± 0.7
Preop DASHy 62 ± 9.4 59 ± 2.0 55 ± 2.1 61 ± 2.7 69 ± 3.9 64 ± 5.3
OR time (min)y 181 ± 6 181 ± 2 182 ± 3 186 ± 4 189 ± 7 197 ± 11
EBL (mL)y 36 ± 9 56 ± 9 60 ± 8 54 ± 10 67 ± 37 60 ± 16
Fluid (L)y 2.6 ± 0.4 3.0 ± 0.1 3.0 ± 0.1 3.2 ± 0.1 3.3 ± 0.3 3.0 ± 0.2
ASM (g)y 6.7 ± 0.4 7.5 ± 0.2 7.9 ± 0.2 7.8 ± 0.3 7.4 ± 0.5 7.8 ± 0.5
MSM (g)y 4.9 ± 0.6 5.7 ± 0.2 6.1 ± 0.3 5.5 ± 0.3 7.7 ± 1.1 5.5 ± 0.4
LOS (days)y 4.7 ± 0.9 4.3 ± 0.1 4.6 ± 0.2 4.6 ± 0.4 4.4 ± 0.4 4.2 ± 0.3
Drain (L)y 0.7 ± 0.1 1.1 ± 0.9 1.2 ± 0.1 1.1 ± 0.2 0.8 ± 0.2 0.6 ± 0.9
Drain (days)y 5.9 ± 0.5 5.8 ± 0.1 5.9 ± 0.2 5.9 ± 0.4 5.7 ± 0.5 5.5 ± 0.3
Lymph Leakz 0 (0%) 1 (1%) 2 (2%) 2 (4%) 0 (0%) 1 (6%)
Readmitz 0 (0%) 3 (3%) 4 (5%) 2 (4%) 0 (0%) 2 (12%)
Postop DASHy 41 ± 13.5 41 ± 2.7 37 ± 2.6 47 ± 3.8 46 ± 5.0 54 ± 6.1
D DASHy 12 ± 7.9 23 ± 5.9 20 ± 2.8 14 ± 3.1 23 ± 5.9 12 ± 7.9
D DASH %y 44 ± 16.3 25 ± 5.5 30 ± 5.0 24 ± 6.2 31 ± 7.1 5 ± 15.3
Improved %z 86% 70% 75% 81% 86% 60%
Data shown represent the number and percentage of patients or the mean ± SEM for each BMI group.
ASM, anterior scalene muscle specimen weight; D (delta), numerical decrease in DASH score from preoperative to 3-month
postoperative follow-up; Drain, output from closed-suction drain after operative procedure, expressed for total volume (liters) and
time until drain removal (days); Improved, percentage of patients exhibiting a decrease in DASH score at 30-day follow-up; Fluid,
intraoperative fluid administered; LOS, length of hospital stay after operative procedure; Lymph leak, number and percentage of
patients requiring early reoperation to control a persistent lymph leak; MSM, middle scalene muscle specimen weight; Postop,
postoperative follow-up 3 months after surgical treatment; OR time, duration of operative procedure; Readmit, hospital
readmission within 30 days of discharge.
*P < 0.05, ANOVA for differences between BMI groups.
yP > 0.05, ANOVA for differences between BMI groups.
zP > 0.05, Chi-square for differences between BMI groups.
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no pain medications or only nonsteroidal anti-
inflammatory drugs to manage symptoms of NTOS
before surgical treatment, over one-quarter were
taking opiates (10% strong opiates and 18% weak
opiates) (Fig. 2G, H). Three-quarters of the patients
were working (44% full time and 8% part time) or
students (23%) at the time of surgery, with the
remainder either unemployed (9%) or disabled
(16%) (Fig. 3A, B). The mean preoperative DASH
score was 59.1 ± 1.2, reflecting a substantial level
of functional disability (Fig. 3C, D). Although there
were significant associations between previous
injury and BMI, and between work status and
BMI, no correlations were observed between BMI
and co-existing medical conditions, incidence or
type of injury, duration of symptoms, pain medica-
tion use, previous operations, or preoperative
DASH scores (Figs. 2 and 3).
Surgical Treatment
All patients underwent supraclavicular thoracic
outlet decompression, with 243 (92%) having
concomitant ipsilateral pectoralis minor tenotomy.
As shown in Table I, the overall mean duration of
operation (incision to wound closure) was
184 ± 2 minutes (range, 72e306 minutes). The
mean estimated blood loss (EBL) was 57 ± 5 mL
(range, 0e700 mL), and the amount of fluid admin-
istered was 3.0 ± 0.1 liters (range, 0.5e6.5 liters),
with no patients requiring blood transfusion. The
specimen weights of the resected anterior and mid-
dle scalene muscles were 7.7 ± 0.1 and
5.8 ± 0.2 grams, respectively, with a total scalene
muscle weight of 13.5 ± 0.2 grams. Mean hospital
length of stay was 4.5 ± 0.1 days (range,
2.7e21.9 days). Mean total postoperative drain vol-
ume was 1053 ± 72 mL, and drain duration was
5.8 ± 0.1 days. Six patients (2%) underwent early
reoperation for control of a persistent lymph leak
that had not responded to conservative measures
(clear liquid diet, parenteral nutrition, and octreo-
tide). There were 11 (4%) readmissions within
30 days of operation, all for unsatisfactory outpa-
tient control of postoperative pain. There was a sig-
nificant correlation between BMI and duration of
operation, but no significant differences between
BMI groups for duration of operation, EBL, amount
Fig. 1. Body mass index in patients undergoing surgical
treatment for neurogenic thoracic outlet syndrome. (A)
Histogram illustrating the distribution of BMI in 265 pa-
tients. (B) Bar graph demonstrating the mean (±SEM)
BMI for patients in each of the 6 BMI groups, with a sig-
nificant difference between groups (ANOVA). The num-
ber of patients in each group is indicated in parentheses.
(C) Scatter plot illustrating correlation analysis between
BMI and patient age. (D) Bar graph showing the mean
(±SEM) age for each BMI group, with a significant di-
fference between groups (ANOVA). UW, underweight;
N, normal; OW, overweight; Ob-I, obese-I; Ob-II,
obese-II; Ob-III, obese-III.
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Fig. 2. Presenting characteristics of patients with NTOS
in relation to BMI. (A and B) Frequency of previous
injury in patients with NTOS (A) and relationship be-
tween BMI and previous injury (B), with a significant
difference between groups (ANOVA). (C and D) Fre-
quency of different duration of symptoms in patients
with NTOS (C) and relationship between BMI and dura-
tion of symptoms (D), with no significant difference be-
tween groups (ANOVA). (E and F) Frequency of
previous operations in patients with NTOS (E) and
relationship between BMI and previous operations (F),
with no significant difference between groups (ANOVA).
(G and H) Frequency of preoperative pain medication
use in patients with NTOS (G) and relationship between
BMI and pain medication use (H), with no significant dif-
ference between groups (ANOVA). NSAIDs, nonsteroidal
anti-inflammatory drugs; Recr, recreational;
Accid, accidental; Occup, occupational; Repet, repetitive
strain; CTS, carpal tunnel syndrome.
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of fluid administered, scalene muscle weight, hospi-
tal length of stay, total drain volume, drain duration,
incidence of lymph leaks requiring reoperation, or
incidence of readmissions (Table I and Fig. 4).
Functional Outcomes
DASH scores were obtained at 3 months after sur-
gery as an indicator of early functional response to
surgical treatment, with 245 patients (92%)
providing satisfactory follow-up data (Table I). The
mean follow-up DASH score was 41.6 ± 1.6, which
compared favorably with the mean preoperative
DASH score of 59.1 ± 1.2 (P < 0.0001, Manne
Whitney test). The mean numerical change in
DASH score was 17.6 ± 1.6, and the mean percent-
age change in DASH score was 26.3 ± 3.0%, with
an improvement in DASH score exhibited by 196
(74%) of patients. There were no correlations with
BMI or differences between BMI groups for changes
in DASH score, the percentage changes in DASH
score, or the proportion of patients with measure-
able functional improvement (Table I and Fig. 5).
Multivariate logistic regression was used to
further analyze associations between various
preoperative patient characteristics and postopera-
tive functional outcome, asmeasured by the percent
improvement in DASH score at 3-month follow-up.
As shown in Table II, none of the BMI groups
exhibited a significant association with functional
improvement. Of the variables assessed, only an un-
employment work status before surgery was signif-
icantly (negatively) associated with functional
outcome (odds ratio 0.236, 95% confidence interval
0.086e0.610, P ¼ 0.004).
DISCUSSION
In this study, we examined the potential effects of
bodyweight on various aspects of surgical treatment
for NTOS. The average BMI in the study cohort
(27.2 kg/m2) was in the overweight range, but there
was a wide and even distribution of body weights
indicating a sufficiently representative sample of pa-
tients across the entire body weight spectrum. We
also evaluated a relatively large number of patients
undergoing surgical treatment for NTOS, thereby
providing an ample basis for analysis. Because all
patients who met the predefined diagnostic criteria
Fig. 3. Preoperative functional status of patients with
NTOS in relation to BMI. (A and B) Frequency of work
status in patients with NTOS (A) and relationship be-
tween BMI and work status (B), with a significant differ-
ence between groups (ANOVA). (C) Scatter plot
illustrating correlation analysis between BMI and preop-
erative DASH score. (D) Bar graph showing the mean
(±SEM) preoperative DASH score for each BMI group,
with no significant difference between groups (ANOVA).
Unemp, unemployed.
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Fig. 4. Operative outcomes of patients with NTOS in
relation to BMI. (A and B) OR time. Scatter plot illus-
trating correlation analysis between BMI and operating
room time (A), showing a significant association, and
bar graph showing the mean (±SEM) operating room
time for each BMI group, with no significant difference
between groups (ANOVA). (C and D) Hospital length
of stay (LOS). Scatter plot illustrating correlation analysis
between BMI and LOS (A), showing no significant asso-
ciation, and bar graph showing the mean (±SEM) LOS
for each BMI group, with no significant difference
between groups (ANOVA). (E and F) Total drain volume.
Scatter plot illustrating correlation analysis between BMI
and drain volume (A), showing no significant associa-
tion, and bar graph showing the mean (±SEM) drain vol-
ume for each BMI group, with no significant difference
between groups (ANOVA). (G and H) Drain duration.
Scatter plot illustrating correlation analysis between
BMI and drain duration (A), showing no significant asso-
ciation, and bar graph showing the mean (±SEM) drain
duration for each BMI group, with no significant differ-
ence between groups (ANOVA).
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and surgical indications for NTOS during the study
period underwent surgical treatment, and there
was no inherent patient-selection bias on the basis
of body weight.
NTOS is a relatively uncommon condition caused
by predisposing variations in anatomy combined
with hypertrophy, injury, and persistent spasm of
the scalene and/or pectoralis minor muscles.15,27
Therewas an association between BMI and underly-
ing mechanism of injury because the average BMI
for occupational-associated injuries was somewhat
higher than those with recreation-associated
injuries. In addition, those identified as disabled or
unemployed had a higher mean BMI relative to
part-time workers or students, but this variation
was not seen between disabled/unemployed and
those employed full time. In examining other pre-
operative characteristics of patients with NTOS,
there was a mild association between BMI and
increasing age, but BMI was independent of gender,
side effects, and the presence of an underlying bony
abnormality. Although half of the patients had un-
derlying co-existing medical conditions in addition
to NTOS, most were psychological in nature and
not influenced by body weight. Indeed, the inci-
dence of diabetes in the study population was only
2.3%, allowing us to examine any potential influ-
ence of obesity in relative isolation. We therefore
found no evidence to suggest that body weight
had a significant causal relationship to the develop-
ment or clinical presentation of NTOS.
Patients with NTOS have often had symptoms for
long periods of time before clinical diagnosis, as well
as confounding previous surgical procedures and
chronic use of opioid pain medications. Consistent
with previous studies, 67% of the study cohort
had exhibited symptoms for more than 1 year and
46% for more than 2 years, 18% had undergone
previous surgical procedures involving the ipsilat-
eral neck and/or extremity, and 28% were taking
Fig. 5. Functional outcomes of patients with NTOS in
relation to BMI. (A and B) Follow-up change (delta) in
DASH score. Scatter plot illustrating correlation analysis
between BMI and 3-month follow-up change in DASH
score (A), showing no significant association, and bar
graph showing the mean (±SEM) follow-up change in
DASH score for each BMI group, with no significant dif-
ference between groups (ANOVA). (C and D) Follow-up
percentage change (delta percent) in DASH score. Scatter
plot illustrating correlation analysis between BMI and
3-month follow-up percentage change in DASH score
(A), showing no significant association, and bar graph
showing the mean (±SEM) follow-up percentage change
in DASH score for each BMI group, with no significant
difference between groups (ANOVA).
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opioid medications; however, there were no signifi-
cant associations found between BMI and the time
interval to clinical presentation, type of interval sur-
gery, or pain medication use. The characteristics of
the patients in this study were therefore generally
comparable with those of others with NTOS, both
in our earlier studies and in those from others, across
the body weight spectrum.29
Given that supraclavicular decompression for
NTOS involves mobilization of the scalene fat pad
and requires careful dissection deepwithin the ante-
rior neck, we suspected that obesity might have had
an adverse influence on the technical conduct of
surgery or on early postoperative complications,
such as wound infection and persistent lymph
drainage. However, there were no significant differ-
ences between the 6 BMI categories in the length of
operation, intraoperative blood loss, amount of fluid
administered, scalene muscle weight, or hospital
length of stay and no differences in the amount of
lymphatic fluid production or drain duration. Hospi-
tal readmission rate was also not associated with
BMI, suggesting that those patients at the higher
end of the BMI spectrum did not impose greater
risks for operation or elevated health-care costs in
the setting of treatment for NTOS.
We assessed DASH scores with regard to the
extent of disability at initial presentation and func-
tional outcomes of surgical treatment, a validated
measure of upper extremity disability that has
been used in previous studies on NTOS.17e21,24,29
The high level of pretreatment functional disability
exhibited by patients in this study is reflected by
the mean preoperative DASH score of 59.1 ± 1.2,
similar to that observed in previous studies on
NTOS from our center and others.17e21,24,29 Most
importantly, the changes in DASH scores after surgi-
cal treatment were not significantly different be-
tween BMI groups, either as evaluated by the
change in absolute DASH scores or by the percent-
age change from preoperative baseline levels. This
finding suggests that the benefit of supraclavicular
decompression for disabling NTOS is maintained
across the body weight spectrum, with those who
are obese gaining the same benefits from operation
as those at ‘‘normal’’ weight, and at similar levels
of surgical risk. Thus, obesity alone should not be
used to disqualify patients from being considered
for surgical decompression.
One limitation of this study is that the patient
population described here may not be representa-
tive of all patients with NTOS but reflects that of a
specialty practice focused on this relatively uncom-
mon condition. The results described here are also
specific to NTOS and do not necessarily translate to
surgical treatment of venous or arterial forms of
TOS. Moreover, the high volume of operative expe-
rience in our center may be associated with tech-
nical approaches and perioperative care processes
that are not necessarily used in other settings.22,23
It is therefore not clear whether the results of this
study can be generalized to other vascular surgery
or thoracic surgery practice environments where
NTOS may be treated on a far less frequent basis.
A second limitation is that the results of this study
are applicable only to supraclavicular thoracic outlet
decompression, as opposed to other surgical ap-
proaches used for NTOS, such as transaxillary first
rib resection. This concern may be particularly rele-
vant given that these 2 operative approaches
involve significant differences in patient posi-
tioning, surgical exposure, and the extent of decom-
pression that can be accomplished (e.g., partial
versus complete scalenectomy and feasibility of
Table II. Logistic regression analysis of operative
outcomes for patients with NTOS
Variable OR 95% CI P Value
Age 0.975 0.949e1.000 0.055
Male gender 0.567 0.292e1.109 0.095







BMI group: obese-I 2.080 0.903e5.037 0.093
BMI group: obese-II 1.913 0.470e9.980 0.393




























Multivariate logistic regression was used to analyze associations
between various preoperative patient characteristics and
postoperative functional outcome, as measured by a decrease
(improvement) in DASH score at 3-month follow-up.
CI, confidence interval; OR, odds ratio.
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brachial plexus neurolysis). It is therefore not yet
clear if the results described here can also be
extended to any potential influence of body weight
on outcomes of transaxillary first rib resection in the
treatment of NTOS.
CONCLUSIONS
This study demonstrated no substantive influence of
BMI on preoperative characteristics, intraoperative
findings, technical results, or early postoperative
outcomes for patients undergoing supraclavicular
decompression for NTOS and no indication of an
‘‘obesity paradox’’ for this condition. Supraclavicu-
lar decompression for NTOS can therefore be safely
and effectively performed and achieve similar out-
comes, across the body weight spectrum. It is not
known if these findings can be extrapolated to other
operative approaches for NTOS.
This work was supported by the Thoracic Outlet Syndrome
Research and Education Fund of the Barnes-Jewish Hospital
Foundation, St. Louis, Missouri.
REFERENCES
1. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of child-
hood and adult obesity in the United States, 2011-2012.
JAMA 2014;311:806e14.
2. Hawn MT, Bian J, Leeth RR, et al. Impact of obesity on
resource utilization for general surgical procedures. Ann
Surg 2005;241:821e6.
3. Morgan MA, Lewis WG, Hopper AN, et al. Prognostic signif-
icance of body mass indices for patients undergoing esopha-
gectomy for cancer. Dis Esophagus 2007;20:29e35.
4. Mullen JT, Davenport DL, Hutter MM, et al. Impact of body
mass index on perioperative outcomes in patients undergo-
ing major intra-abdominal cancer surgery. Ann Surg Oncol
2008;15:2164e72.
5. Mullen JT, Moorman DW, Davenport DL. The obesity
paradox: body mass index and outcomes in patients under-
going nonbariatric general surgery. Ann Surg 2009;250:
166e72.
6. King DR, Velmahos GC. Difficulties in managing the surgical
patient who is morbidly obese. Crit Care Med
2010;38(9 Suppl):S478e82.
7. Johnson ON 3rd, Sidawy AN, Scanlon JM, et al. Impact of
obesity on outcomes after open surgical and endovascular
abdominal aortic aneurysm repair. J Am Coll Surg
2010;210:166e77.
8. Giles KA, Wyers MC, Pomposelli FB, et al. The impact of
body mass index on perioperative outcomes of open and
endovascular abdominal aortic aneurysm repair from the
National Surgical Quality Improvement Program, 2005-
2007. J Vasc Surg 2010;52:1471e7.
9. Giles KA, Hamdan AD, Pomposelli FB, et al. Body mass in-
dex: surgical site infections and mortality after lower
extremity bypass from the National Surgical Quality
Improvement Program 2005-2007. Ann Vasc Surg
2010;24:48e56.
10. Mariscalco G, Wozniak MJ, Dawson AG, et al. Body mass in-
dex and mortality among adults undergoing cardiac surgery:
a nationwide study with a systematic review and meta-anal-
ysis. Circulation 2017;135:850e63.
11. Galyfos G, Geropapas GI, Kerasidis S, et al. The effect of body
mass index on major outcomes after vascular surgery. J Vasc
Surg 2017;65:1193e207.
12. Benjamin ER, Dilektasli E, Haltmeier T, et al. The effects of
body mass index on complications and mortality after emer-
gency abdominal operations: the obesity paradox. Am J Surg
2017;214:899e903.
13. Poirier P, Giles TD, Bray GA, et al., American Heart Associ-
ation., Obesity Committee of the Council on nutrition,
physical Activity, and Metabolism. Obesity and cardiovas-
cular disease: pathophysiology, evaluation, and effect of
weight loss: an update of the 1997 American Heart Associ-
ation Scientific Statement on Obesity and Heart Disease
from the Obesity Committee of the Council on Nutrition,
Physical Activity, and Metabolism. Circulation 2006;113:
898e918.
14. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al.,
BMI-CHD Collaboration Investigators. Association of over-
weight with increased risk of coronary heart disease partly
independent of blood pressure and cholesterol levels: a
meta-analysis of 21 cohort studies including more than
300,000 persons. Arch Intern Med 2007;167:1720e8.
15. Thompson RW, Driskill M. Thoracic outlet syndrome:
neurogenic. In: Cronenwett JL, Johnston KW eds. Ruther-
ford’s Vascular Surgery. 7th ed. Philadelphia: Elsevier,
2010. pp 1878e98.
16. Jordan SE, Ahn SS, Gelabert HA. Differentiation of thoracic
outlet syndrome from treatment-resistant cervical brachial
pain syndromes: development and utilization of a question-
naire, clinical examination and ultrasound evaluation. Pain
Physician 2007;10:441e52.
17. Cordobes-Gual J, Lozano-Vilardell P, Torreguitart-Mirada N,
et al. Prospective study of the functional recovery after sur-
gery for thoracic outlet syndrome. Eur J Vasc Endovasc Surg
2008;35:79e83.
18. Chang DC, Rotellini-Coltvet LA, Mukherjee D, et al. Surgi-
cal intervention for thoracic outlet syndrome improves pa-
tient’s quality of life. J Vasc Surg 2009;49:630e7.
19. Glynn RW, Tawfick W, Elsafty Z, et al. Supraclavicular sca-
lenectomy for thoracic outlet syndrome: functional out-
comes assessed using the DASH scoring system. Vasc
Endovascular Surg 2012;46:157e62.
20. Caputo FJ, Wittenberg AM, Vemuri C, et al. Supraclavicular
decompression for neurogenic thoracic outlet syndrome in
adolescent and adult populations. J Vasc Surg 2013;57:
149e57.
21. Vemuri C, Wittenberg AM, Caputo FJ, et al. Early effective-
ness of isolated pectoralis minor tenotomy in selected pa-
tients with neurogenic thoracic outlet syndrome. J Vasc
Surg 2013;57:1345e52.
22. Duwayri YM, Thompson RW. Supraclavicular approach for
surgical treatment of thoracic outlet syndrome. In:
Chaikof EL, Cambria RP eds. Atlas of vascular surgery and
endovascular therapy. Philadelphia: Elsevier Saunders,
2014. pp 172e92.
23. Thompson RW, Vemuri C. Neurogenic thoracic outlet syn-
drome exposure and decompression: supraclavicular. In:
Volume 49, May 2018 Body weight and neurogenic thoracic outlet syndrome 89
Mulholland MW, HawnMT, Hughes SJ, et al. eds. Operative
techniques in surgery. Philadelphia: Wolters Kluwer Health,
2015. pp 1848e61.
24. Thompson RW. Development of consensus-based diagnostic
criteria for NTOS. In: Illig KA, Thompson RW, Freischlag JA,
et al. eds. Thoracic outlet syndrome. London, UK: Springer,
2013. pp 143e55.
25. Rochlin DH, Gilson MM, Likes KC, et al. Quality-of-life
scores in neurogenic thoracic outlet syndrome patients un-
dergoing first rib resection and scalenectomy. J Vasc Surg
2013;57:436e43.
26. Likes KC, Orlando MS, Salditch Q, et al. Lessons learned in
the surgical treatment of neurogenic thoracic outlet
syndrome over 10 years. Vasc Endovascular Surg 2015;49:
8e11.
27. Thompson RW, Dawkins C, Vemuri C, et al. Performance
metrics in professional baseball pitchers before and after sur-
gical treatment for neurogenic thoracic outlet syndrome.
Ann Vasc Surg 2017;39:216e27.
28. Sanders RJ, Hammond SL, Rao NM. Diagnosis of thoracic
outlet syndrome. J Vasc Surg 2007;46:601e4.
29. Balderman J, Holzem K, Field BJ, et al. Associations be-
tween clinical diagnostic criteria and pre-treatment pa-
tient-reported outcomes measures in a prospective
observational cohort of patients with neurogenic thoracic
outlet syndrome. J Vasc Surg 2017;66:533e44.
90 Ohman et al. Annals of Vascular Surgery
